Literature DB >> 32560225

Transcriptional Regulation of Natural Killer Cell Development and Functions.

Dandan Wang1,2, Subramaniam Malarkannan1,2,3,4.   

Abstract

Natural killer (NK) cells are the major lymphocyte subset of the innate immune system. Their ability to mediate anti-tumor cytotoxicity and produce cytokines is well-established. However, the molecular mechanisms associated with the development of human or murine NK cells are not fully understood. Knowledge is being gained about the environmental cues, the receptors that sense the cues, signaling pathways, and the transcriptional programs responsible for the development of NK cells. Specifically, a complex network of transcription factors (TFs) following microenvironmental stimuli coordinate the development and maturation of NK cells. Multiple TFs are involved in the development of NK cells in a stage-specific manner. In this review, we summarize the recent advances in the understandings of TFs involved in the regulation of NK cell development, maturation, and effector function, in the aspects of their mechanisms, potential targets, and functions.

Entities:  

Keywords:  IL-12; IL-15; IL-2; IL-21; NK cell; development; transcription factors

Year:  2020        PMID: 32560225     DOI: 10.3390/cancers12061591

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  11 in total

1.  The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residency.

Authors:  Sigrid Wahlen; Filip Matthijssens; Wouter Van Loocke; Sylvie Taveirne; Laura Kiekens; Eva Persyn; Els Van Ammel; Zenzi De Vos; Stijn De Munter; Patrick Matthys; Filip Van Nieuwerburgh; Tom Taghon; Bart Vandekerckhove; Pieter Van Vlierberghe; Georges Leclercq
Journal:  Elife       Date:  2022-07-06       Impact factor: 8.713

2.  Differential regulation of transcription factor T-bet induction during NK cell development and T helper-1 cell differentiation.

Authors:  Difeng Fang; Kairong Cui; Yaqiang Cao; Mingzhu Zheng; Takeshi Kawabe; Gangqing Hu; Jaspal S Khillan; Dan Li; Chao Zhong; Dragana Jankovic; Alan Sher; Keji Zhao; Jinfang Zhu
Journal:  Immunity       Date:  2022-04-04       Impact factor: 43.474

3.  Declined miR-181a-5p expression is associated with impaired natural killer cell development and function with aging.

Authors:  Jiao Lu; Shan Li; Xiaopeng Li; Wenming Zhao; Xuefeng Duan; Xiuling Gu; Jianqiao Xu; Bolan Yu; Luis J Sigal; Zhongjun Dong; Lixin Xie; Min Fang
Journal:  Aging Cell       Date:  2021-03-29       Impact factor: 9.304

Review 4.  Human NK cells: From development to effector functions.

Authors:  Arosh Shavinda Perera Molligoda Arachchige
Journal:  Innate Immun       Date:  2021-03-24       Impact factor: 2.680

5.  Single-Cell Sequencing Reveals the Novel Role of Ezh2 in NK Cell Maturation and Function.

Authors:  Minghang Yu; Ziyang Su; Xuefeng Huang; Xi Wang
Journal:  Front Immunol       Date:  2021-10-26       Impact factor: 7.561

Review 6.  Cytokine-induced memory-like natural killer cells for cancer immunotherapy.

Authors:  Mubin Tarannum; Rizwan Romee
Journal:  Stem Cell Res Ther       Date:  2021-12-04       Impact factor: 6.832

7.  A novel membrane-bound interleukin-2 promotes NK-92 cell persistence and anti-tumor activity.

Authors:  Qi Xiong; Hantao Zhang; Xuanle Ji; Yong Zhang; Gang Shi; Lei Dai; Fuyi Cheng; Huiling Wang; Jieyan Luo; Jia Xu; Yanhong Ji; Xiaolan Su; Weixiao Yang; Lin Zhang; Hongxin Deng
Journal:  Oncoimmunology       Date:  2022-09-22       Impact factor: 7.723

8.  TXNIP Promotes Human NK Cell Development but Is Dispensable for NK Cell Functionality.

Authors:  Eva Persyn; Sigrid Wahlen; Laura Kiekens; Sylvie Taveirne; Wouter Van Loocke; Els Van Ammel; Filip Van Nieuwerburgh; Tom Taghon; Bart Vandekerckhove; Pieter Van Vlierberghe; Georges Leclercq
Journal:  Int J Mol Sci       Date:  2022-09-26       Impact factor: 6.208

9.  CD56-negative NK cells: Frequency in peripheral blood, expansion during HIV-1 infection, functional capacity, and KIR expression.

Authors:  Alexander T H Cocker; Fuguo Liu; Zakia Djaoud; Lisbeth A Guethlein; Peter Parham
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

10.  Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer.

Authors:  Changxin Wan; Matthew P Keany; Han Dong; Linah F Al-Alem; Unnati M Pandya; Suzan Lazo; Karsten Boehnke; Katherine N Lynch; Rui Xu; Dominique T Zarrella; Shengqing Gu; Paloma Cejas; Klothilda Lim; Henry W Long; Kevin M Elias; Neil S Horowitz; Colleen M Feltmate; Michael G Muto; Michael J Worley; Ross S Berkowitz; Ursula A Matulonis; Marisa R Nucci; Christopher P Crum; Bo R Rueda; Myles Brown; Xiaole Shirley Liu; Sarah J Hill
Journal:  Cancer Res       Date:  2020-11-06       Impact factor: 13.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.